Suprascapular Nerve Block as Postoperative Analgesia After Artroscopic Shoulder Surgery

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this randomized study is to examine the effect of a selective suprascapular nerve block on post operative pain after arthroscopic shoulder surgery. Half of the subjects will receive a active nerve block with Ropivacain. Half of the subjects will receive a placebo nerve block with saline.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kai Henrik Wiborg Lange
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

• Patients planned for arthroscopic shoulder surgery.

• Age ≥ 18.

• ASA class ≤ 3.

Exclusion Criteria:

• Patients with VAS never ≥5 mm during the first hour after arrivel to the post anesthesia care unit.

• Patients unable to cooperate.

• Patients unable to understand or speak danish.

• Allergy towards the used drugs.

• Abuse of alcohol- and/or medicine - investigators assessment.

• Usage of opioids on a daily basis (not including Tramadole).

• Pregnancy (It is obligatory for all fertile women in the study to take a hcg urine test).

• Operations involving the clavicle.

• Operations converted to open surgery.